Depression and suicidality with VMAT2 inhibitors in tardive dyskinesia A signal detection from the FDA Adverse Events Reporting System
Yuma Yokoi,
Hiroko Kashiwagi,
Daisuke Funada,
Shingo Yamashita,
Chika Kubota
Affiliations
Yuma Yokoi
Department of Educational Promotion, Clinical Research & Education Promotion Division, National Center Hospital National Center of Neurology and Psychiatry Tokyo Japan
Hiroko Kashiwagi
Department of Forensic Psychiatry, National Center Hospital National Center of Neurology and Psychiatry Tokyo Japan
Daisuke Funada
Department of Forensic Psychiatry, National Center Hospital National Center of Neurology and Psychiatry Tokyo Japan
Shingo Yamashita
Department of Psychiatry, National Center Hospital National Center of Neurology and Psychiatry Tokyo Japan
Chika Kubota
Department of Psychiatry, National Center Hospital National Center of Neurology and Psychiatry Tokyo Japan
